ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

Howard Hughes Medical Institute Seeks up to 25 New Researchers

January 17, 2014

Dole Visits Roswell Park, Hails PSA Test

January 28, 1994

AACI Remains Split On Guidelines; Terry Proposes 25 Percent Limit On Staff Investigator Salaries

January 30, 1981